EXCLUSIVE: SCIENTURE Secures Formulary Coverage For REZENOPY; Commercial Launch Planned For Mid-July
Benzinga Newsdesk 4 months ago
NewsFDAExclusives
5,000+ Healthcare Facilities Reached ThroughGPO Agreements, Covering ~60% of Institutional GPO MarketU.S. naloxone market totals ~$144 million in annual sales and ~9.8 million units annually,represents significant
5,000+ Healthcare Facilities Reached Through
GPO Agreements, Covering ~60% of Institutional GPO Market
U.S. naloxone market totals ~$144 million in annual sales and ~9.8 million units annually,
represents significant commercial opportunity for REZENOPY™